Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00653
|
|||||
| Drug Name |
Phenacetin
|
|||||
| Synonyms |
4'-Ethoxyacetanilide; 4-Ethoxyacetanilide; 62-44-2; Acetamide, N-(4-ethoxyphenyl)-; Acetophenetidin; Acetophenetidine; Acetophenetin; Acetphenetidin; Achrocidin; Codempiral; Commotional; Contradol; Contradouleur; Fenacetina; Fenidina; Fenina; Imidazo[4,5-e][1,4]diazapine nucleotide (I); Kalmin; N-(4-Ethoxyphenyl)acetamide; Pertonal; Phenacet; Phenacetine; Phenacetinum; Phenacitin; Phenazetin; Phenazetina; Phenedina; Phenidin; Phenin; Phenodyne; Pyraphen; Stellacyl; Tetracydin; p-Acetophenetide; p-Acetophenetidide; p-Acetophenetidine; p-Acetphenetidin; p-Ethoxyacetanilide
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C10H13NO2
|
|||||
| Canonical SMILES |
CCOC1=CC=C(C=C1)NC(=O)C
|
|||||
| InChI |
InChI=1S/C10H13NO2/c1-3-13-10-6-4-9(5-7-10)11-8(2)12/h4-7H,3H2,1-2H3,(H,11,12)
|
|||||
| InChIKey |
CPJSUEIXXCENMM-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 62-44-2
|
|||||
| Pharmaceutical Properties | Molecular Weight | 179.22 | Topological Polar Surface Area | 38.3 | ||
| Heavy Atom Count | 13 | Rotatable Bond Count | 3 | |||
| Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 2 | |||
| XLogP |
1.6
|
|||||
| PubChem CID | ||||||
| PubChem SID |
10321803
, 10530552
, 11112166
, 11335755
, 11360994
, 11363676
, 11366238
, 11368800
, 11372367
, 11374228
, 11376962
, 11461966
, 11466561
, 11467681
, 11485715
, 11486202
, 11489756
, 11491219
, 11492330
, 11494596
, 12016023
, 14748329
, 16962413
, 17389770
, 22388565
, 24858936
, 24887192
, 24890660
, 26611996
, 26679408
, 26747350
, 26747351
, 26752986
, 26752987
, 29223838
, 3139201
, 36018734
, 3724298
, 46507394
, 47440229
, 47959721
, 48035093
, 73483
, 7348354
, 7847635
, 8147859
, 8149602
, 8152917
, 841972
, 9793
|
|||||
| ChEBI ID |
ChEBI:8050
|
|||||
| TTD Drug ID | ||||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.